Viewing Study NCT00120835


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-01-27 @ 8:40 AM
Study NCT ID: NCT00120835
Status: COMPLETED
Last Update Posted: 2010-06-10
First Post: 2005-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Genotype-1 View
None Treatment-Naive View